Gastrointestinal immunity plays a crucial role in defending the body against pathogens while maintaining tolerance to the trillions of microbes inhabiting the gut. The gut-associated lymphoid tissue (GALT) comprises Peyer's patches, lymph nodes, and other immune structures that coordinate immune responses in the digestive tract. Specialized immune cells, such as intraepithelial lymphocytes and mucosa-associated lymphoid tissue, contribute to the surveillance of the intestinal lining. Immunoglobulin A (IgA) antibodies, abundantly produced in the gastrointestinal mucosa, play a central role in neutralizing pathogens and regulating the gut microbiota. Tolerance mechanisms prevent the immune system from overreacting to harmless antigens or commensal bacteria, maintaining homeostasis. Gastrointestinal infections and inflammatory conditions, like inflammatory bowel disease (IBD), can result from dysregulation of gastrointestinal immunity. The gut-brain axis highlights the interconnectedness of gastrointestinal and neurological functions. Nutrition, particularly components like dietary fiber, influences gastrointestinal immunity. Probiotics and prebiotics contribute to a healthy gut microbiota, positively impacting immune function. Understanding the intricate balance of gastrointestinal immunity is vital for addressing digestive disorders and promoting overall health. Ongoing research explores the modulation of gut immunity for therapeutic interventions and the potential links between gut health and systemic conditions.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States
Title : Hypersensitivity and anti-SARS-COV-2 vaccination: A retrospective study of the year 2021 at the University Hospital Center of Tours (France)
Faure Quentin, The Savoie Metropolitan Hospital Center, France
Title : THE HPV vaccination program in Colombia. From a beautiful dream to a nightmare, but hopefully with a bright dawn.
Carlos Castro, Colombian League against cancer, Colombia